StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > 1+1=3

<< Previous

Bullboard Posts

Next >>

Comment by Pacman28on Oct 25, 2021 4:21pm

147 Views

Post# 34046917

RE:RE:RE:RE:1+1=3

Execution is clearly taking place?..? I'd like to hear how You came up with that theory. clear to me would be regular updates on the flagship Aristotle blood test that Tripp calls a game changer. I hope their doing testing.... but clear ,it is not

<< Previous

Bullboard Posts

Next >>

BMO evolves InvestorLine with enhanced tools for options trading